Found: 65
Select item for more details and to access through your institution.
Emergence of linezolid-resistant coagulase-negative Staphylococcus in a cancer centre linked to increased linezolid utilization.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2010, v. 65, n. 9, p. 2001, doi. 10.1093/jac/dkq238
- By:
- Publication type:
- Article
Post-Obstructive Pneumonia in Patients with Cancer: A Review.
- Published in:
- Infectious Diseases & Therapy, 2018, v. 7, n. 1, p. 29, doi. 10.1007/s40121-018-0185-2
- By:
- Publication type:
- Article
In vitro growth rates are clues to sites and susceptibility.
- Published in:
- JAAPA: Journal of the American Academy of Physician Assistants (Haymarket Media, Inc.), 2013, v. 26, n. 3, p. 18, doi. 10.1097/01720610-201303000-00005
- By:
- Publication type:
- Article
Effective alternatives in the face of a growing problem.
- Published in:
- JAAPA: Journal of the American Academy of Physician Assistants (Haymarket Media, Inc.), 2013, v. 26, n. 2, p. 13, doi. 10.1097/01720610-201302000-00004
- By:
- Publication type:
- Article
Tailoring management to patient characteristics.
- Published in:
- JAAPA: Journal of the American Academy of Physician Assistants (Haymarket Media, Inc.), 2013, v. 26, n. 1, p. 18, doi. 10.1097/01720610-201301000-00005
- By:
- Publication type:
- Article
OSTEOMYELITIS: Drug bioavailability and bone penetration are key.
- Published in:
- JAAPA: Journal of the American Academy of Physician Assistants (Haymarket Media, Inc.), 2012, v. 25, n. 7, p. 21, doi. 10.1097/01720610-201207000-00005
- By:
- Publication type:
- Article
MRSA INFECTIONS: The use of vancomycin and alternative drugs.
- Published in:
- JAAPA: Journal of the American Academy of Physician Assistants (Haymarket Media, Inc.), 2012, v. 25, n. 6, p. 22, doi. 10.1097/01720610-201206000-00005
- By:
- Publication type:
- Article
SURGICAL SITE INFECTION: Knowledge of the likely pathogens is key.
- Published in:
- JAAPA: Journal of the American Academy of Physician Assistants (Haymarket Media, Inc.), 2012, v. 25, n. 5, p. 27, doi. 10.1097/01720610-201205000-00005
- By:
- Publication type:
- Article
URINARY TRACT INFECTION: Consistent therapy to reduce resistance.
- Published in:
- JAAPA: Journal of the American Academy of Physician Assistants (Haymarket Media, Inc.), 2012, v. 25, n. 3, p. 23, doi. 10.1097/01720610-201203000-00006
- By:
- Publication type:
- Article
ANTIMICROBIAL STEWARDSHIP: A proactive approach to combating resistance.
- Published in:
- JAAPA: Journal of the American Academy of Physician Assistants (Haymarket Media, Inc.), 2012, v. 25, n. 2, p. 22, doi. 10.1097/01720610-201202000-00004
- By:
- Publication type:
- Article
BATTLING INFLUENZA: Universal vaccination is the primary weapon.
- Published in:
- JAAPA: Journal of the American Academy of Physician Assistants (Haymarket Media, Inc.), 2012, v. 25, n. 1, p. 27, doi. 10.1097/01720610-201201000-00006
- By:
- Publication type:
- Article
The emerging problem of bacterial resistance in cancer patients; proceedings of a workshop held by MASCC "Neutropenia, Infection and Myelosuppression" Study Group during the MASCC annual meeting held in Berlin on 27-29 June 2013.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Reply.
- Published in:
- Journal of Infectious Diseases, 1994, v. 170, n. 5, p. 1344, doi. 10.1093/infdis/170.5.1344-a
- By:
- Publication type:
- Article
A Randomized Double-Blind Trial of Vancomycin versus Teicoplanin for the Treatment of Gram-Positive Bacteremia in Patients with Cancer.
- Published in:
- Journal of Infectious Diseases, 1994, v. 169, n. 2, p. 350
- By:
- Publication type:
- Article
Mississippi mud in the 1990s.
- Published in:
- Cancer (0008543X), 1998, v. 83, n. 12, p. 2597, doi. 10.1002/(SICI)1097-0142(19981215)83:12<2597::AID-CNCR27>3.0.CO;2-L
- By:
- Publication type:
- Article
A prospective crossover randomized trial of novobiocin and rifampin prophylaxis for the prevention of intravascular catheter infections in cancer patients treated with interleukin-2.
- Published in:
- 1998
- By:
- Publication type:
- journal article
A comparison of aztreonam plus vancomycin and imipenem plus vancomycin as initial therapy for febrile neutropenic cancer patients.
- Published in:
- Cancer (0008543X), 1996, v. 77, n. 7, p. 1386, doi. 10.1002/(SICI)1097-0142(19960401)77:7<1386::AID-CNCR25>3.0.CO;2-X
- By:
- Publication type:
- Article
The Use of New and Better Antibiotics for Bacterial Infections in Patients With Leukemia.
- Published in:
- Clinical Lymphoma & Myeloma, 2009, v. 9, p. S357, doi. 10.3816/CLM.2009.s.035
- By:
- Publication type:
- Article
Once daily, oral, outpatient quinolone monotherapy for low‐risk cancer patients with fever and neutropeniaThese data were presented in part as abstract 375 at the 41st Annual Meeting of the Infectious Diseases Society of America, San Diego, California, October 9‐12, 2003.: A pilot study of 40 patients based on validated risk‐prediction rules
- Published in:
- Cancer (0008543X), 2006, v. 106, n. 11, p. 2489
- By:
- Publication type:
- Article
Vancomycin tolerance, a potential mechanism for refractory gram‐positive bacteremia observational study in patients with cancerThis study was presented, in part, at the 13th International Symposium on Infections in the Immunocompromised Host, International Immunocompromised Host Society (ICHS), Granada, Spain, June 27–30, 2004.
- Published in:
- Cancer (0008543X), 2006, v. 106, n. 8, p. 1815
- By:
- Publication type:
- Article
Bacterial infections in low‐risk, febrile neutropenic patientsPresented in part as abstract 376 at the 41st Annual Meeting of the Infectious Diseases Society of America, San Diego, California, October 9–12, 2003.: Over a decade of experience at a comprehensive cancer center
- Published in:
- Cancer (0008543X), 2005, v. 104, n. 2, p. 422, doi. 10.1002/cncr.21144
- By:
- Publication type:
- Article
Strongyloidiasis in patients at a comprehensive cancer center in the United States.
- Published in:
- Cancer (0008543X), 2004, v. 100, n. 7, p. 1531
- By:
- Publication type:
- Article
The burdens of cancer therapy.
- Published in:
- Cancer (0008543X), 2004, v. 100, n. 6, p. 1324
- By:
- Publication type:
- Article
Treatment of febrile neutropenic patients with cancer who require hospitalization.
- Published in:
- Cancer (0008543X), 2003, v. 98, n. 5, p. 1039
- By:
- Publication type:
- Article
Infections in patients with aplastic anemia.
- Published in:
- Cancer (0008543X), 2003, v. 98, n. 1, p. 86
- By:
- Publication type:
- Article
Daptomycin use in neutropenic patients with documented gram-positive infections.
- Published in:
- Supportive Care in Cancer, 2014, v. 22, n. 1, p. 7, doi. 10.1007/s00520-013-1947-8
- By:
- Publication type:
- Article
Current microbiology of percutaneous endoscopic gastrostomy tube (PEG tube) insertion site infections in patients with cancer.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Oral moxifloxacin for outpatient treatment of low-risk, febrile neutropenic patients.
- Published in:
- Supportive Care in Cancer, 2010, v. 18, n. 1, p. 89, doi. 10.1007/s00520-009-0634-2
- By:
- Publication type:
- Article
In vitro Antimicrobial Activity of Gatifloxacin Compared with Other Quinolones against Clinical Isolates from Cancer Patients.
- Published in:
- Chemotherapy (0009-3157), 2004, v. 50, n. 5, p. 214, doi. 10.1159/000081708
- By:
- Publication type:
- Article
High Rates of Nonsusceptibility to Ceftazidime-avibactam and Identification of New Delhi Metallo-β-lactamase Production in Enterobacteriaceae Bloodstream Infections at a Major Cancer Center.
- Published in:
- Clinical Infectious Diseases, 2016, v. 63, n. 7, p. 954, doi. 10.1093/cid/ciw398
- By:
- Publication type:
- Article
Development and Validation of a Clinical Model to Predict the Presence of β-Lactam Resistance in Viridans Group Streptococci Causing Bacteremia in Neutropenic Cancer Patients.
- Published in:
- Clinical Infectious Diseases, 2014, v. 59, n. 2, p. 223, doi. 10.1093/cid/ciu260
- By:
- Publication type:
- Article
Editorial Commentary: Cryptococcosis due to Cryptococcus gattii.
- Published in:
- Clinical Infectious Diseases, 2013, v. 57, n. 4, p. 552, doi. 10.1093/cid/cit342
- By:
- Publication type:
- Article
In vitro activity of dalbavancin and five comparator agents against common and uncommon Gram-positive organisms isolated from cancer patients.
- Published in:
- Journal of Antibiotics, 2016, v. 69, n. 5, p. 381, doi. 10.1038/ja.2015.120
- By:
- Publication type:
- Article
New antimicrobial agents for the treatment of bacterial infections in cancer patients.
- Published in:
- Hematological Oncology, 2009, v. 27, n. 3, p. 107, doi. 10.1002/hon.898
- By:
- Publication type:
- Article
Activity of Cefsulodin, other β-Lactams, and Aminoglycosides against Pseudomonas aeruginosa.
- Published in:
- Chemotherapy (0009-3157), 1984, v. 30, n. 3, p. 165, doi. 10.1159/000238263
- By:
- Publication type:
- Article
The Activity of Ceftazidime, Other β-Lactams, and Aminoglycosides against Pseudomonas aeruginosa.
- Published in:
- Chemotherapy (0009-3157), 1984, v. 30, n. 1, p. 31, doi. 10.1159/000238241
- By:
- Publication type:
- Article
In-vitro activity of PD 117 596, a new quinolone, against bacterial isolates from cancer patients.
- Published in:
- 1990
- By:
- Publication type:
- journal article
Oral ciprofloxacin therapy for infections in cancer patients.
- Published in:
- 1989
- By:
- Publication type:
- journal article
In-vitro activity of PD 117558, a new quinolone against bacterial isolates from cancer patients.
- Published in:
- 1989
- By:
- Publication type:
- journal article
In-vitro activity of LY146032 against gram-positive isolates from cancer patients.
- Published in:
- 1987
- By:
- Publication type:
- journal article
Ceftizoxime plus ticarcillin: double β-lactam therapy for infections in cancer patients.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 1987, v. 19, n. 3, p. 367
- By:
- Publication type:
- Article
In-vitro susceptibility of Pseudomonas species to fifteen antimicrobial agents.
- Published in:
- 1987
- By:
- Publication type:
- journal article
Activity of CI-934 against Gram-positive bacteria.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 1986, v. 18, n. 6, p. 768
- By:
- Publication type:
- Article
In-vitro activity of Sch 34343, a new penam, against Gram-positive isolates from cancer patients.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 1986, v. 18, n. 2, p. 159
- By:
- Publication type:
- Article
In-vitro activity of cefpirome (HR-810), WIN-49375, BMY-28142 and other antibiotics against nosocomially important isolates from cancer patients.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 1986, v. 17, n. 4, p. 453
- By:
- Publication type:
- Article
In-vitro activity of RU 28965, a new macrolide, compared to that of erythromycin.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 1986, v. 17, n. 2, p. 161
- By:
- Publication type:
- Article
Species dependent variability in the susceptibility of coagulase-negative staphylococci to various antimicrobial agents.
- Published in:
- 1985
- By:
- Publication type:
- journal article
Diffusion of ceftriaxone into the cerebrospinal fluid of adults.
- Published in:
- 1984
- By:
- Publication type:
- journal article
Antimicrobial tolerance in group C and group G streptococci.
- Published in:
- 1984
- By:
- Publication type:
- journal article
The penetration of cefmenoxime into cerebrospinal fluid across non-inflamed meninges.
- Published in:
- 1983
- By:
- Publication type:
- journal article